• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by The Valens Company Inc.

    1/17/23 8:46:25 AM ET
    $VLNS
    Get the next $VLNS alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 001-41080
    Issuer: Valens Company, Inc.
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 230 Carion Road
    Kelowna BRITISH COLUMBIA, CANADA V4V 2K5 CA
    Telephone number: 1-647-264-9105
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Common Shares
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2023-01-17 By Tara Petta AVP
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $VLNS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $VLNS

    DatePrice TargetRatingAnalyst
    3/3/2022Market Perform → Underperform
    Raymond James
    More analyst ratings

    $VLNS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SNDL Completes Acquisition of The Valens Company

      Creates a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue1 CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for tota

      1/17/23 8:32:00 AM ET
      $SNDL
      $VLNS
      Medicinal Chemicals and Botanical Products
      Health Care
    • THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDL

      KELOWNA, BC, Jan. 3, 2023 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement

      1/3/23 1:19:00 PM ET
      $SNDL
      $VLNS
      Medicinal Chemicals and Botanical Products
      Health Care
    • The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

      KELOWNA, BC, Dec. 13, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the Company meeting the continued listing requirement for mar

      12/13/22 6:30:00 PM ET
      $VLNS

    $VLNS
    SEC Filings

    See more
    • SEC Form 15-12G filed by The Valens Company Inc.

      15-12G - Valens Company, Inc. (0001859902) (Filer)

      1/27/23 8:12:07 AM ET
      $VLNS
    • SEC Form F-10POS filed by The Valens Company Inc.

      F-10POS - Valens Company, Inc. (0001859902) (Filer)

      1/17/23 10:51:15 AM ET
      $VLNS
    • SEC Form 6-K filed by The Valens Company Inc.

      6-K - Valens Company, Inc. (0001859902) (Filer)

      1/17/23 10:48:49 AM ET
      $VLNS

    $VLNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Valens Co downgraded by Raymond James

      Raymond James downgraded Valens Co from Market Perform to Underperform

      3/3/22 4:41:15 AM ET
      $VLNS

    $VLNS
    Leadership Updates

    Live Leadership Updates

    See more
    • The Valens Company Appoints New Board Chair and Provides an Update on its Annual General Meeting of Shareholders

      KELOWNA, BC, May 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of branded cannabis products, today announced that it has separated the roles of Chair and Chief Executive Officer (CEO) and appointed Andrew Cockwell as its new Chair of the Board, effective immediately.  This decision follows the Company's recent Nasdaq listing and its commitment to governance best practices including transparency and accountability. Tyler Robson has stepped down as Chair in full support of this decision and will remain on the Board and as the CEO of the Company.

      5/16/22 5:00:00 PM ET
      $VLNS

    $VLNS
    Financials

    Live finance-specific insights

    See more
    • Valens Semiconductor to Announce Second Quarter 2022 Financial Results on August 10, 2022

      HOD HASHARON, Israel,, July 20, 2022 /PRNewswire/ -- Valens Semiconductor (NYSE:VLN), a premier provider of high-speed connectivity solutions for the audio-video and automotive markets, today announced that it will release its second quarter 2022 financial results before the market opens on Wednesday, August 10, 2022. In conjunction with this announcement, Valens will host a conference call on Wednesday, August 10, 2022, at 8:30 a.m. Eastern Time (ET) to discuss its second quarter 2022 financial results and business outlook. To access this call, dial +1 (888) 642-5032 (U.S.), 0 (800) 917-5108 (UK), 03 918 0609 (Israel) or +972 3 918 0609 (all other locations). A live webcast of the conferenc

      7/20/22 8:00:00 AM ET
      $VLN
      $VLNS
      Semiconductors
      Technology
    • The Valens Company Reports Second Quarter Fiscal 2022 Financial Results

      Realized initial benefits of Integration Initiatives, with SG&A as a percent of revenue declining 908 basis points in Q2 2022 from Q1 2022 In five months, Valens has actioned $15 million in annual cost savings and has identified in excess of $5 million additional cost savings to be actioned over the next few quarters exceeding management's original $20 million target Achieved double-digit revenue growth in Green Roads, B2B, & International revenue segments. Provincial sales rebounded strongly in June with record monthly revenue Top 10 licensed producer in Canada, with a 3.2% market share for three months ending May 2022 Valens reiterates its objective of achieving positive adjusted EBITDA(2

      7/13/22 5:00:00 PM ET
      $VLNS
    • The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022

      KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Thursday, July 14, 2022, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the financial results and business outlook. Participant Dial-In

      7/6/22 5:00:00 PM ET
      $VLNS